By Jeff Brown
Mutual fund investors need to watch out for an unexpected and in some respects undeserved tax bill in any investing between now and the year's end.
U.S. stock futures are mixed; a rates announcement from the Federal Reserve is expected Wednesday afternoon; Trian launches campaign to break up DuPont; Endo makes bid for Auxilium.
By Brian O'Connell
High-debt millennials may think they're staying out of financial trouble by forgoing credit cards, but they're going to need a good credit history sooner rather than later.
Macstercard (MA) declared an 11 cent quarter dividend today payable November 10.
Och-Ziff Capital Management (OZM) shares are down after the California Public Employees' Retirement System announced that it would be divesting the $700 million Och-Ziff was handling for it.
Everyone's clamoring for the mother of all IPOs. But here's why bank stocks are a better bet.
FactSet Research Systems (FDS) shares are down despite matching and beating analysts earnings and revenue expectations.
Here's a close technical look at five financial stocks to trade for gains in September -- four to buy and one to sell.
U.S. stock futures fall; the Federal Reserve begins a two-day meeting; Alibaba raises price range of its IPO; Boeing poised to get award to build space taxi, a report says.
Bankrate (RATE) shares are dropping after the company announced an SEC investigation into its financial reporting from 2012.
Billionaire William Ackman is planning an initial public offering of one of his funds on Euronext Amsterdam.
The second Affordable Care Act open enrollment period is just weeks away but some Americans are still reeling from scams spawned by the initial Obamacare rollout.
By Hal M. Bundrick
As the second open enrollment period looms, scams from last year are still being mopped up.
eBay shares shot up last week, after rumors surfaced that Google could look to acquire a major minority stake in the online auction company.
U.S. stock futures are lower; Heineken rejects a takeover bid from rival SABMiller; Danaher to buy the Swiss dental-implant maker Nobel Biocare; Netflix expands further into Europe.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV